![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-24-2023-89772.pdf
https://professionals.optumrx.com/content/dam/optum3/professional-optumrx/news/rxnews/drug-recalls-shortages/drugshortage_zerbaxa_2021-0423.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-13-2021-1610520934.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-6-2021-1609918562.pdf
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-merck-canada-incs-zerbaxa-1608715038.pdf
https://medicalxpress.com/news/2020-07-ceftolozanetazobactam-treatment-option-severe-infections.html
https://www.businesswire.com/news/home/20200506005158/en/Results-Phase-3-Trial-Evaluating-Efficacy-Safety
https://www.biospace.com/article/merck-s-recarbrio-shows-success-in-late-stage-trial-for-habp-vabp-patients/
https://endpts.com/merck-touts-phase-iii-data-for-antibacterial-recarbrio-sanofi-to-ax-200-jobs-in-japan-report/
https://www.fiercepharma.com/pharma/as-officials-grapple-antimicrobial-resistance-merck-scores-fda-approval-for-new
https://in.reuters.com/article/us-merck-co-fda/mercks-treatment-for-urinary-abdominal-infections-gets-fda-approval-idINKCN1UC19W
https://www.reuters.com/article/us-antibiotics-regulator/fresenius-says-tighter-eu-rules-could-trigger-antibiotic-shortage-idUSKCN1T6257
https://www.fiercepharma.com/pharma/merck-scores-zerbaxa-label-expansion-years-after-cubist-buyout
https://www.businesswire.com/news/home/20190413005021/en/Results-Phase-3-Trial-Evaluating-Merck%E2%80%99s-ZERBAXA%C2%AE/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==
https://endpts.com/merck-heralds-a-rare-big-pharma-success-for-antibiotic-phiii-but-its-also-a-cautionary-tale-about-the-market/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204959
https://www.pharmacompass.com/pdf/news/hospira-healthcare-india-pvt-ltd-on-fda-import-alert-list-1549480434.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-18-2018-1531894333.pdf
http://www.pharmatimes.com/news/antibiotic_supply_chains_on_brink_of_collapse_1237955
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-23-2018-1527054176.pdf
https://www.pharmacompass.com/pdf/news/apotex-corp-issues-voluntary-nationwide-recall-of-piperacillin-and-tazobactam-for-injection-1526359925.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207848
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206204
http://www.prnewswire.com/news-releases/zavante-therapeutics-zolyd-met-primary-endpoint-in-pivotal-zeus-study-for-treatment-of-complicated-urinary-tract-infections-300435655.html
http://www.in-pharmatechnologist.com/Ingredients/Fresenius-Kabi-wants-Wockhardt-to-change-wrong-BSE-filing
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206996
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206204
https://www.pharmacompass.com/pdf/news/us-fda-enforcement-report-8june2016-1465388450.pdf
http://www.reuters.com/article/us-india-health-drugs-idUSKCN0VO2H3
http://www.news-medical.net/news/20150826/Mylan-releases-generic-version-of-Zosyn-Injection-in-the-US.aspx?
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53910a-eng.php
http://www.fiercepharmamanufacturing.com/story/drug-shortages-becomes-issue-teva-and-mylan-hook/2015-04-30
http://www.mercknewsroom.com/news-release/corporate-news/merck-announces-publication-pivotal-data-phase-3-clinical-studies-zerbax
http://www.fiercepharma.com/story/what-does-mercks-10b-buyback-plan-say-about-pharma-ma/2015-03-26
http://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Piperacillin+and+Tazobactam+%28Zosyn%29+Injection&source=govdelivery&st=c&tab=tabs-4&utm_medium=email&utm_source=govdelivery
http://www.fiercepharma.com/story/merck-losing-breakthrough-tag-hep-c-treatment-earnings-hit-mark/2015-02-04
http://www.fiercebiotech.com/story/singapores-merlion-eyes-partner-phase-iii-finafloxacin-urinary-infection-tr/2015-01-27